Literature DB >> 17118672

Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota.

Karen Smith1, Kathy D McCoy, Andrew J Macpherson.   

Abstract

Vertebrates are essentially born germ-free but normally acquire a complex intestinal microbiota soon after birth. Most of these organisms are non-pathogenic to immunocompetent hosts; in fact, many are beneficial, supplying vitamins for host nutrition and filling the available microbiological niche to limit access and consequent pathology when pathogens are encountered. Thus, mammalian health depends on mutualism between host and flora. This is evident in inflammatory conditions such as inflammatory bowel disease, where aberrant responses to microbiota can result in host pathology. Studies with axenic (germ-free) or deliberately colonised animals have revealed that commensal organisms are required for the development of a fully functional immune system and affect many physiological processes within the host. Here, we describe the technical requirements for raising and maintaining axenic and gnotobiotic animals, and highlight the extreme diversity of changes within and beyond the immune system that occur when a germ-free animal is colonized with commensal bacteria.

Entities:  

Mesh:

Year:  2006        PMID: 17118672     DOI: 10.1016/j.smim.2006.10.002

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  268 in total

Review 1.  The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA.

Authors:  Neeraj K Surana; Dennis L Kasper
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 2.  Control of antiviral immunity by pattern recognition and the microbiome.

Authors:  Iris K Pang; Akiko Iwasaki
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

3.  The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota.

Authors:  June L Round; S Melanie Lee; Jennifer Li; Gloria Tran; Bana Jabri; Talal A Chatila; Sarkis K Mazmanian
Journal:  Science       Date:  2011-04-21       Impact factor: 47.728

4.  Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease.

Authors:  Mark J Asquith; Olivier Boulard; Fiona Powrie; Kevin J Maloy
Journal:  Gastroenterology       Date:  2010-04-28       Impact factor: 22.682

5.  Gut immune maturation depends on colonization with a host-specific microbiota.

Authors:  Hachung Chung; Sünje J Pamp; Jonathan A Hill; Neeraj K Surana; Sanna M Edelman; Erin B Troy; Nicola C Reading; Eduardo J Villablanca; Sen Wang; Jorge R Mora; Yoshinori Umesaki; Diane Mathis; Christophe Benoist; David A Relman; Dennis L Kasper
Journal:  Cell       Date:  2012-06-22       Impact factor: 41.582

Review 6.  Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota.

Authors:  Paige V Bauer; Sophie C Hamr; Frank A Duca
Journal:  Cell Mol Life Sci       Date:  2015-11-05       Impact factor: 9.261

7.  Addressing the experimental variability associated with the microbiota.

Authors:  G Eberl
Journal:  Mucosal Immunol       Date:  2015-04-08       Impact factor: 7.313

Review 8.  Interactions between host and gut microbiota in domestic pigs: a review.

Authors:  Yadnyavalkya Patil; Ravi Gooneratne; Xiang-Hong Ju
Journal:  Gut Microbes       Date:  2019-11-24

9.  Response of germ-free mice to colonization with O. formigenes and altered Schaedler flora.

Authors:  Xingsheng Li; Melissa L Ellis; Alexander E Dowell; Ranjit Kumar; Casey D Morrow; Trenton R Schoeb; John Knight
Journal:  Appl Environ Microbiol       Date:  2016-09-23       Impact factor: 4.792

10.  Differential induction of antimicrobial REGIII by the intestinal microbiota and Bifidobacterium breve NCC2950.

Authors:  Jane M M Natividad; Christina L Hayes; Jean-Paul Motta; Jennifer Jury; Heather J Galipeau; Vivek Philip; Clara L Garcia-Rodenas; Hiroshi Kiyama; Premysl Bercik; Elena F Verdu
Journal:  Appl Environ Microbiol       Date:  2013-10-04       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.